NCT06612255View on ClinicalTrials.gov

A Study Comparing the Bioavailability of a Taste-masked Delafloxacin Powder for Oral Suspension With the Delafloxacin Tablet in Healthy Adults

PHASE1TerminatedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

June 3, 2024

Primary Completion Date

September 11, 2024

Study Completion Date

September 11, 2024

Conditions
Healthy
Interventions
DRUG

Delafloxacin

Delafloxacin tablet

DRUG

Delafloxacin Powder

Delafloxacin powder for oral suspension formulation

Trial Locations (1)

NG11 6JS

Quotient Sciences, Ruddington

Sponsors
All Listed Sponsors
collaborator

Biomedical Advanced Research and Development Authority

FED

lead

Melinta Therapeutics, Inc.

INDUSTRY